Latest Biologic Stories
ANNAPOLIS, Md., Oct.
LONDON, Oct. 7, 2014 /PRNewswire/ -- INTRODUCTIONThe injectable drug delivery market holds significant potential for the future.
Physicians Indicate that Switching of Currently Treated Patients to Biosimilar Infliximab Is Likely to be Limited, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
International Plasma Awareness Week, October 12-18 ANNAPOLIS, Md., Oct.
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
- BIO Investor Forum to be held October 7-8 in San Francisco - SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Pfenex Inc.
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio THOUSAND OAKS, Calif., Oct.
Transparency Market Research has published a new report titled "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a full agenda
A Different Mechanism of Action from the Currently Available Products is Entyvio's Most Commonly Cited Advantage, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.